• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board

    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

    Acutus Medical Receives FDA Clearance of AcQCross

    Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Trademark Plastics Inc.

    maxon

    Forefront Medical Technology

    Qosina Corp.

    MW Life Sciences
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Unicep

    MW Life Sciences

    FUTEK Advanced Sensor Technology Inc.

    Qosina Corp.

    Creganna Medical, part of TE Connectivity
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Unlocking Market Doors with Real-World Evidence

    Real-world evidence is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards.

    Unlocking Market Doors with Real-World Evidence
    Bringing RWE together. Image courtesy of Veeva Systems.
    Related CONTENT
    • CROs are Undergoing Major Changes to Speed Clinical Trials
    • Admedus Turns Focus to TAVR Market
    • NDH Medical Inc.
    • Managing Risks for Medical Devices: A Guide to Understanding ISO 14971
    • FlowMet-R Gets FDA 510K Clearance
    Seth Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems11.04.19
    Market access is a significant challenge for today’s medical device and diagnostics manufacturers. New global regulatory requirements are one contributing factor. For example, Europe’s new Medical Device Regulation (MDR) will require companies to provide stronger clinical evidence on the efficacy, safety, and value of their products. In the U.S., the Food and Drug Administration (FDA) set new expectations for risk assessment for medical devices and diagnostics.

    In addition to more complicated regulations, the industry now faces demands from a larger group of diverse stakeholders—regulators, payers, providers, hospitals, hospital networks, patients, and advocacy groups—each with different priorities and varying levels of influence on market access. Device and diagnostics companies must now provide broader, more value-based data to obtain coverage from payers. This information will also satisfy inquiries from budget-conscious public healthcare systems looking more holistically at the long-term benefits on patient care.

    Real-world evidence (RWE) is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards. However, the scale and complexity of unstructured data makes it difficult for companies to assemble and analyze it because much of this data is spread across information silos. To unlock market access, manufacturers require new data-driven solutions that can bring together diverse sources of information for a more complete view of all the ways their products can help patients.

    Addressing the Concerns of More Diverse Stakeholders
    Over the past three decades, device companies only needed strong clinical evidence a product worked as described and provided a clinical benefit to patients.1 In addition to product safety and efficacy evidence, companies must now show health economic information that demonstrates product value to a wide range of stakeholders—each of which may define value differently.

    National hospital networks, for example, often buy devices in bulk and want to know the value of using new products or procedures before making a large investment. Medical device and diagnostics manufacturers must provide meaningful information beyond statistical outcome, such as findings on the long-term benefits to the healthcare system and patient. In addition to a product’s intended purpose, manufacturers must outline product value, long-term cost savings, length of patient recovery, and other information to help healthcare decision-makers determine the products that will provide the best patient care within their budgets.

    The same is true for payers, which typically have the greatest influence on market access. In the past, a CPT code plus coverage meant reimbursement. However, a CPT code no longer equates to automatic reimbursement from insurers. Today, medical device and diagnostics companies must show proof of long-term value to stakeholders. They must present clinical data and real-world evidence their product will save money because of a shortened hospital stay, elimination of a secondary procedure, or other benefits.

    “Insurance providers, both private and public, are no longer relying solely on the opinions of medical experts or clinical trial data to make coverage decisions. They are increasingly looking at cost effectiveness as the gating factor for payment,” explained Shantanu Gaur, M.D., co-founder and chief scientific officer at medical device company Allurion Technologies.2

    Leveraging All the Right Data to Demonstrate Value
    There are many databases medical device and diagnostics companies can mine to find evidence of their product’s value to patients, but no single source provides a complete view. Most common examples are claims databases, EMR/EHRs, health surveys, social media, patient-generated health data (PGHD), and patient registries.

    Claims databases combine all patient claims submitted by healthcare providers (HCPs) to payers. They are a common source of information for payers, but don’t include any other information. HCPs input routine clinical and laboratory data into EMR/EHR systems, but some worry about the quality of the data in these systems as physicians experience “EMR fatigue.”

    PGHD offers data from patients, family members, and caregivers. It usually includes health history, biometric data, symptoms, and lifestyle choices. PGHD can provide an inside view of a patient’s health, quality of life, and adherence to a treatment plan, enabling timely intervention before a costly care episode. However, this data source also comes with complications. For example, providers need to set up advanced analytical tools, build processes into their workflow, and determine what information to include in patient EHRs.

    Not all providers can take these extra measures. Some providers are concerned about potential negative impacts on efficiency, increased liability risk, and setting realistic patient expectations. Some patients’ low health and technical literacy could also negatively affect the accuracy of PGHD. Other obstacles include the need to manage potential security risks, address patients’ privacy concerns, and standardize the data collected from multiple devices.

    In addition to these sources, there are open data sources such as pharmacy databases and health insurance records. These systems are primarily maintained for billing and administration, but can also be used by researchers, insurers, health authorities, and other stakeholders to provide long-term data on the impact of health interventions on the healthcare system in real-world observational studies.

    Payers, governments, and hospital networks are already leveraging various combinations of these data sources to determine market access. Likewise, medical device and diagnostics companies must look at it all, including more RWE to identify trends and fill in gaps from any individual data sources. By combining all sources, manufacturers can provide a holistic analysis of a product’s long-term value to regulators, healthcare organizations, providers, and more importantly, patients. Unfortunately, this has been a challenge for medical device and diagnostics manufacturers.

    Aggregating Various Sources of Real-World Evidence
    RWE has not lived up to expectations, largely due to a lack of technology available to manage it all effectively. To add complexity, real-world data comes in both structured and unstructured formats, making it difficult to bring it all together for a complete picture. Device/diagnostics companies can only look at one data set at a time, rather than in aggregate for greater analysis.

    Fortunately, technology is now available to bring structured and unstructured data together at any scale as a “data lake” in a single, centralized system. Medical device and diagnostics companies can store this data without having to structure it first, and can then apply next-generation analytics tools—from dashboards and visualizations to big-data processing, real-time analytics, and artificial intelligence—to identify trends that reinforce a strong product value proposition.

    Not too long ago, medical device and diagnostics manufacturers didn’t require such sophisticated systems, and instead could get by using manual tools to analyze fewer data points—they only needed to appeal to a limited audience with fewer demands. A published paper was often sufficient evidence to prove the viability of a product or procedure. With greater data demands from a wider range of stakeholders and much larger studies across regions, these methods are no longer sufficient. Today, advanced clinical data management technology integrated with electronic data capture functionality enables manufacturers to manage all of their data in one system.

    Medical device and diagnostics companies also now require flexible solutions to handle changing requirements and more sources of relevant data. Compared with the rigidity of FDA requirements, payer requests for data are fuzzier, often changing cyclically and differing among private insurers. Agile, cloud-based systems that are easily adaptable to changing needs are an important foundation for communicating product value to secure faster market access. Additionally, these systems should include data functionality robust enough to manage large data lakes and enable advanced data analysis.

    Modernize to Get Access
    As regulators, payers, and healthcare systems restructure market access for the medical device and diagnostics industry, manufacturers require modern, flexible technology to analyze both unstructured and structured data from multiple data sources in one environment. This is the key to unlocking those hard-to-budge market access doors. New, fuller data sets and sophisticated technologies will empower device and diagnostics companies to bring their innovative therapies to patients fast. 

    References
    1. STAT News, “3 Hurdles to Bringing Medical Devices to Market,” by Shantanu Gaur, (September 27, 2018).
    2. Med Device Online, “Getting Medtech Covered: Payer Strategy Best Practices” by Tong, Kuo and Navigant, Raj Stewart, (2018).


    Seth Goldenberg, a former director at NAMSA where he supported medical device companies from inception through commercialization and post-market activities, understands this new paradigm better than most. Now, as vice president of Medical Devices & Diagnostics at Veeva Systems, Goldenberg is overseeing the development of a sophisticated cloud technology platform that will drive the process efficiencies and speed that the industry needs today. New to Veeva, Goldenberg is excited to bring his passion in medical devices to the life sciences cloud technology company. He can be reached at seth.goldenberg@veeva.com.
    Related Searches
    • security
    • healthcare
    • technologies
    • europe
    Related Knowledge Center
    • Software & IT
    Suggested For You
    CROs are Undergoing Major Changes to Speed Clinical Trials CROs are Undergoing Major Changes to Speed Clinical Trials
    Admedus Turns Focus to TAVR Market Admedus Turns Focus to TAVR Market
    NDH Medical Inc. NDH Medical Inc.
    Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971 Managing Risks for Medical Devices: A Guide to Understanding ISO 14971
    FlowMet-R Gets FDA 510K Clearance FlowMet-R Gets FDA 510K Clearance
    Six NICU Device Innovators Share $150K in Awards Six NICU Device Innovators Share $150K in Awards
    FDA Publishes 4 Draft Guidances in Continuing Effort to Modernize 510(k) FDA Publishes 4 Draft Guidances in Continuing Effort to Modernize 510(k)
    Alternative Sterilization Technology for Medical Device Companies Alternative Sterilization Technology for Medical Device Companies
    Innovating for the Clinical Space: An Interview with Clinical Innovations Innovating for the Clinical Space: An Interview with Clinical Innovations' President/CEO Ken Reali
    Semiconductor Industry Innovator Joins PrinterPrezz’s Board of Advisors Semiconductor Industry Innovator Joins PrinterPrezz’s Board of Advisors
    FDA Approves Alcon FDA Approves Alcon's AcrySof IQ PanOptix Trifocal IOL, the First Trifocal Lens
    Medtronic Evolut TAVR System Gains Approval for Expanded Indications Medtronic Evolut TAVR System Gains Approval for Expanded Indications
    Turning a Regulatory Headache into a Competitive Advantage Turning a Regulatory Headache into a Competitive Advantage
    The Future of Medtech Manufacturing The Future of Medtech Manufacturing
    Selecting the Right Manufacturer to Ensure Reduced Sterilization Risk Selecting the Right Manufacturer to Ensure Reduced Sterilization Risk

    Related Columns

    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21

    • Software & IT
      The Five Steps Toward Machine Learning

      The Five Steps Toward Machine Learning

      When talking about AI and ML, we’re no longer discussing the theoretical scenarios science fiction is made of. We’re talking about what’s possible.
      Sue Marchant, Machine Learning and Artificial Intelligence, MasterControl 05.01.20


    • Software & IT
      Expanding Quality Beyond the Four Walls of Your Organization

      Expanding Quality Beyond the Four Walls of Your Organization

      As suppliers can impact product quality, device manufacturers must oversee them as though they were an extension of the company and not an outside entity.
      Seth Goldenberg, Ph.D., and Carl Ning, Veeva Systems 03.04.20

    • Contract Manufacturing | Software & IT
      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Industry 4.0 represents the dawn of the digital transformation that began with the third revolution, connecting the physical and natural worlds.
      Scott Reedy, Senior Director of Marketing, Arena Solutions 10.08.19

    • Contract Manufacturing | Digital Health | Software & IT
      Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      ...
      MPO Staff 07.30.19


    • Software & IT
      Five Strategies to Navigate Regulatory Challenges in Medical Device Development

      Five Strategies to Navigate Regulatory Challenges in Medical Device Development

      ...
      Seth J. Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 07.30.19

    • Software & IT
      Connected Quality Systems Reduce Risks

      Connected Quality Systems Reduce Risks

      ...
      Scott Reedy, Senior Director of Marketing, Arena Solutions 06.13.19

    • Software & IT
      Using Digitization to Get Ahead in Medtech

      Using Digitization to Get Ahead in Medtech

      ...
      Bryant Headley, Customer Success Executive, MasterControl 05.01.19


    • Software & IT
      Quality Systems: It’s All Greek to Us

      Quality Systems: It’s All Greek to Us

      ...
      Dawn A. Lissy, President & Founder, Empirical 04.03.19

    • Software & IT
      Five Questions to Improve Your Requirements Management

      Five Questions to Improve Your Requirements Management

      ...
      Kevin Steigerwald, VP of Product & UX, Jama Software 04.03.19

    • Software & IT
      Digital Transformation: Seven Considerations for Your QMS

      Digital Transformation: Seven Considerations for Your QMS

      ...
      Tony Parise, Product Strategist—Life Sciences, ETQ 04.03.19


    • Software & IT
      Three Questions to Master Continual MDSAP Conformity

      Three Questions to Master Continual MDSAP Conformity

      ...
      Tony Parise, Product Strategist—Life Sciences, ETQ 03.07.19

    • R&D & Design | Software & IT
      Disrupting the Outsourcing Model

      Disrupting the Outsourcing Model

      ...
      Steve Maylish and Shannon White, Fusion Biotec 01.31.19

    • Software & IT
      4 Ways to Prepare for the European Medical Device Regulation (MDR)

      4 Ways to Prepare for the European Medical Device Regulation (MDR)

      ...
      Melonie Warfel, Vice President, Medical Device & Diagnostics, Veeva Systems 01.30.19


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Face Mask Filters 98 Percent Of COVID-19 Particles
    • Thermo Fisher Scientific To Acquire PPD For $17.4 Billion
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    • Acutus Medical Receives FDA Clearance of AcQCross
    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    What You're Reading on Happi.com
    Former L’Oréal Exec Joins Glossier
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login